Calabrese R, et al. - In patients with inoperable MBO (malignant bowel obstruction), researchers investigated palliative medical therapy using combinations of octreotide, dexamethasone and/or metoclopramide. They observed a higher percentage of deobstruction with treating MBO with triple therapy (all three medications) than using no medication, and with octreotide than no octreotide. Compared to no therapy or therapy without octreotide, the days to deobstruction using triple therapy or other combinations with octreotide were significantly higher.